Abstract:The genetic interrogation and reprogramming of cells requires methods for robust and precise targeting of genes for expression or repression. The CRISPR-associated catalytically inactive dCas9 protein offers a general platform for RNA-guided DNA targeting. Here, we show that fusion of dCas9 to effector domains with distinct regulatory functions enables stable and efficient transcriptional repression or activation in human and yeast cells, with the site of delivery determined solely by a coexpressed short guide (sg)RNA. Coupling of dCas9 to a transcriptional repressor domain can robustly silence expression of multiple endogenous genes. RNA-seq analysis indicates that CRISPR interference (CRISPRi)-mediated transcriptional repression is highly specific. Our results establish that the CRISPR system can be used as a modular and flexible DNA-binding platform for the recruitment of proteins to a target DNA sequence, revealing the potential of CRISPRi as a general tool for the precise regulation of gene expression in eukaryotic cells.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to achieve precise and efficient regulation of gene expression in eukaryotic cells. Specifically, the authors explored the use of the catalytically inactive form (dCas9) in the CRISPR/Cas9 system combined with different effector protein domains to achieve this goal. The following are the main problems and purposes of this study: 1. **Develop a modular, programmable RNA - guided DNA - targeting platform**: - By fusing dCas9 with effector protein domains with different regulatory functions, a universal platform is formed for precisely locating specific DNA sequences and recruiting these effector proteins for transcriptional regulation. 2. **Achieve stable transcriptional repression or activation**: - Studies have shown that after dCas9 is fused with a transcriptional repression domain (such as KRAB) or an activation domain (such as VP64, p65AD), it can efficiently and stably repress or activate gene expression in human cells and yeast cells. - Using CRISPR interference (CRISPRi) technology, efficient silencing of endogenous genes can be achieved, and this silencing effect is highly specific. 3. **The ability of multi - gene regulation**: - It is demonstrated that CRISPRi can regulate not only a single gene but also multiple genes simultaneously, thus providing a tool for high - throughput functional genomics research. 4. **Verify the application of CRISPRi in different eukaryotes**: - The research is not limited to human cells but also extends to yeast (such as Saccharomyces cerevisiae), showing the potential of CRISPRi as a universal method for regulating gene expression in various eukaryotes. ### Formulas and Charts To better understand these research results, the following are the explanations of some key formulas and charts: - **sgRNA guides dCas9 to target DNA**: \[ \text{sgRNA}+d\text{Cas9}\to\text{DNA binding} \] This process is achieved through complementary pairing between sgRNA and the target DNA sequence. - **The inhibitory effect of the dCas9 - KRAB fusion protein on GFP expression**: \[ \text{dCas9 - KRAB}+\text{sgRNA targeting GFP}\to\text{5 - fold decrease in GFP signal} \] - **The activation effect of the dCas9 - VP64 fusion protein on the Gal4 UAS - GFP reporter gene**: \[ \text{dCas9 - VP64}+\text{sgRNA targeting Gal4 UAS}\to\text{23 - fold activation of GFP expression} \] ### Conclusion In conclusion, this study has successfully developed a modular platform based on the CRISPR system, which can achieve precise regulation of gene expression in eukaryotic cells in an RNA - guided manner. This method is not only applicable to the regulation of a single gene but can also be extended to multi - gene regulation, and it shows good specificity and efficiency in different types of eukaryotic cells.

CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes

Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression

CRISPR Interference (crispri) for Sequence-Specific Control of Gene Expression

Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system

An enhanced CRISPR repressor for targeted mammalian gene regulation

Programmable Transcriptional Modulation with a Structured RNA-Mediated CRISPR-dCas9 Complex

Specific Modulation of CRISPR Transcriptional Activators through RNA-Sensing Guide RNAs in Mammalian Cells and Zebrafish Embryos

Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

Programmable RNA targeting with the single-protein CRISPR effector Cas7-11

Precise transcript targeting by CRISPR-Csm complexes

Quantitative CRISPR interference screens in yeast identify chemical-genetic interactions and new rules for guide RNA design

Multiplex gene regulation by CRISPR-ddCpf1

Engineered transcription-associated Cas9 targeting in eukaryotic cells

Efficient multiplexed gene regulation in Saccharomyces cerevisiae using dCas12a

EcCas6e-based antisense crRNA for gene repression and RNA editing in microorganisms

CRISPRi-mediated tunable control of gene expression level with engineered single-guide RNA in Escherichia coli

Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors

Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators